Magdalena Bogun

2163-P: Safety and Effectiveness of Automated Insulin Delivery during Labor and the Postpartum Period

Elise L. Huppert, YING CHEN, LIMIN PENG, Noelia Zork et autres

Introduction and Objective: Intravenous (IV) insulin infusion is the standard of care for glucose management during labor and delivery in women with type 1 diabetes. Limited real-world data are available on the safety and effectiveness of automated insulin delivery (AID) during labor …

us (code pays fourni par la source)

Continuous Glucose Monitoring in Hospitalized Adults With Diabetic Ketoacidosis: A Prospective Open-Label Pilot Study

Magdalena Bogun, Chunhui Wang, Paul Kurlansky, Nur Bedeir et autres

BACKGROUND: Continuous glucose monitoring (CGM) devices are increasingly used in critical and non-critical care hospital units. The efficacy of CGM in assessing glucose control in adults with diabetic ketoacidosis (DKA) is unknown. METHODS: This single-center pilot study compared glycemic control by real-time …

us (code pays fourni par la source)

Diabetes workshops for providers improve glucose control in coronary artery bypass grafting patients

Magdalena Bogun, Matthew A. Beier, Sameer K. Singh, Denise McLaughlin et autres

OBJECTIVES: Postoperative hyperglycemia occurs in up to 80% of cardiac surgery patients and is associated with poor outcomes. We sought to determine if case-based diabetes workshops for providers would improve postoperative glycemic control and outcomes in patients undergoing coronary artery bypass grafting …

us (code pays fourni par la source)

Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts

Michael Voss, David Cuthbertson, Mario Cleves, Ping Xu et autres

OBJECTIVE To assess the progression of type 1 diabetes using time to peak glucose or C-peptide during oral glucose tolerance tests (OGTTs) in autoantibody-positive relatives of people with type 1 diabetes. RESEARCH DESIGN AND METHODS We examined 2-h OGTTs of participants in …

us, se (code pays fourni par la source)

Diabetic ketoacidosis and mortality in COVID-19 infection

Jacob S. Stevens, Magdalena Bogun, Donald J. McMahon, Jason Zucker et autres

us (code pays fourni par la source)

Diabetic Ketoacidosis and Mortality in COVID-19 Infection

Jacob S. Stevens, Magdalena Bogun, Donald J. McMahon, Jason Zucker et autres

us (code pays fourni par la source)

C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet

Magdalena Bogun, Brian N. Bundy, Robin Goland, Carla J. Greenbaum

OBJECTIVE: Insulin secretion declines rapidly after diagnosis of type 1 diabetes, followed by a slower rate of change. Previous studies have demonstrated that the C-peptide decline begins before the clinical diagnosis. Changes in insulin secretion in the same individuals studied from preclinical …

us (code pays fourni par la source)

674-P: Glycemic Management Practice Guideline Combined with a Multidisciplinary Champion Team Approach Increased the Use of Basal Bolus Insulin Regimen and Reduced the Use of Sliding Scale Insulin

Magdalena Bogun, Eleanor Zagoren, Kevin Ackerman, Alana Ciolek

Basal-bolus insulin (BBI) therapy is recommended for treatment of hyperglycemia in the inpatient setting, but many patients still receive sliding scale insulin (SSI) that has been shown to be less effective. To evaluate the transition from insulin drip to subcutaneous insulin therapy …

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

Michael J. Haller, S. Alice Long, J. Lori Blanchfield, Desmond Schatz et autres

A three-arm, randomized, double-masked, placebo-controlled phase 2b trial performed by the Type 1 Diabetes TrialNet Study Group previously demonstrated that low-dose anti-thymocyte globulin (ATG) (2.5 mg/kg) preserved β-cell function and reduced HbA1c for 1 year in new-onset type 1 diabetes. Subjects (N …

us (code pays fourni par la source)

Dietary Intervention for Inpatient Glycemic Control

Sara J. Cromer, Magdalena Bogun

While recommendations for inpatient glycemic control suggest a conservative target of 140-180mg/dL, many struggle to achieve this goal. Glycemic control begins with a carbohydrate-controlled diet, but many inpatient diets continue to be suboptimal and can contribute to hyperglycemia. At our institution, the …

Innovative Tailored Microlearning Approach to Insulin Self-Management Education Shows High Engagement Levels among Diverse Adults

Magdalena Bogun, Nicole Jelesoff, Carine M. Nassar, Connie R. Thacker et autres

Self-management education for adults with type 2 diabetes (T2DM) improves knowledge, skills and motivation; yet, new strategies to more effectively educate patients and improve adoption of insulin therapy are still needed. We conducted a prospective, non-randomized multi-center pilot, using a novel Patient …

Inpatient Management of Diabetes and Hyperglycemia

Magdalena Bogun, Silvio E. Inzucchi

us (code pays fourni par la source)